CIAS
GNOM icon

Capital Investment Advisory Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Capital Investment Advisory Services’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
+240
New +$11.4K ﹤0.01% 1129

Other funds holding GNOM

SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
EWM
Evolution Wealth Management Fort Myers, Florida $170M AUM 19.89% 1-Year Est. Return

Capital Investment Advisory Services's GNOM Position: Q2 2026 in Review

Capital Investment Advisory Services opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 240 shares worth $13.6K. The stake represents ﹤0.01% of the portfolio and ranks #1129 among its holdings.

12 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Capital Investment Advisory Services held 240 shares of Global X Genomics & Biotechnology ETF worth $13.6K as of Q2 2026.
  • Global X Genomics & Biotechnology ETF was a new Capital Investment Advisory Services position in Q2 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Capital Investment Advisory Services's portfolio in Q2 2026, its #1129 holding.
  • 12 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.